ABG-WTT Global Life Science Capital Partners GP Ltd

In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), ABG-WTT Global Life Science Capital Partners GP Ltd reported 4 stock positions worth $38.3 million. Its top holding was Ceribell (CBLL) at 54.5% of the portfolio, followed by CG Oncology (CGON, 31.7%) and Rapid Micro Biosystems Class A (RPID, 12.7%). Compared with Q4 2024, it added to 1. The biggest buy was Rapid Micro Biosystems Class A (RPID, shares +78%).

Most Recent 13F
Q2 2026
Location
CENTRAL, HONG KONG, K3
CIK
0001832108
Portfolio Value
$38.3M (Q1 2025)
SEC Filing
0000950123-25-005578 ↗ filed May 15, 2025

Holdings Value

0$10.0M$20.0M$30.0M$40.0M$50.0M Q1 2024: $41.5M Q1 2024 Q2 2024: $30.0M Q2 2024 Q3 2024: $20.1M Q3 2024 Q4 2024: $43.7M Q4 2024 Q1 2025: $38.3M $38.3M Q1 2025 Q2 2025: $26.8M Q2 2025 Q3 2025: $18.7M Q3 2025 Q4 2025: $15.0M Q4 2025 Q1 2026: $12.3M Q1 2026 Q2 2026: $8.6M Q2 2026

Holdings 4 stocks · $38.3M
CBLL Ceribell Inc. 54.54% 1,088,101 $20.9M No change
CGON CG Oncology Inc. 31.67% 495,526 $12.1M No change
RPID Rapid Micro Biosystems Inc. Class A 12.73% 1,848,296 $4.9M Add +78.0%
LUNG Pulmonx Corp. 1.06% 60,204 $405K No change

Portfolio Sells Q4 2024 → Q1 2025
None this quarter.

Portfolio Buys Q4 2024 → Q1 2025
RPID Rapid Micro Biosystems Inc. Class A Add +78.0% 12.73% +10.60

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 2$8.6MCBLL, RPID
Q1 2026 2$12.3MCBLL, RPID
Q4 2025 2$15.0MCBLL, RPID
Q3 2025 2$18.7MCBLL, RPID
Q2 2025 2$26.8MCBLL, RPID
Q1 2025 4$38.3MCBLL, CGON, RPID, LUNG
Q4 2024 4$43.7MCBLL, CGON, RPID, LUNG
Q3 2024 3$20.1MCGON, RPID, LUNG
Q2 2024 3$30.0MCGON, RPID, LUNG
Q1 2024 3$41.5MCGON, RPID, LUNG